In addition, Syntenin-1 upregulates the transcription of IRF1/5/7/9, IL-1β, IL-6, and CCL2 via SRC-1 junction and HIF1α or mTOR activation, thereby exacerbating the inflammation of VEC and RA FLS. Here, CCL2 is linked to rheumatoid arthritis.